Literature DB >> 17622614

Compatibility of the gH homologues of Epstein-Barr virus and related lymphocryptoviruses.

Liguo Wu1, Lindsey M Hutt-Fletcher1.   

Abstract

Glycoprotein gH, together with its chaperone gL and a third glycoprotein gB, is essential for cell-cell fusion and virus-cell fusion mediated by herpesviruses. Epstein-Barr virus (EBV), the prototype human lymphocryptovirus, requires a fourth glycoprotein gp42 to support fusion with B cells in addition to epithelial cells. Two other lymphocryptoviruses, the rhesus lymphocryptovirus (Rh-LCV) and the common marmoset lymphocryptovirus (CalHV3), have been sequenced in their entirety and each has a gp42 homologue. Combinations of proteins from EBV, Rh-LCV and CalHV3 were able to mediate fusion of epithelial cells, but, even when complexed with EBV gp42, only Rh-LCV and not CalHV3 proteins were able to mediate fusion with human B cells. CalHV3 gL was also unable to function effectively as a chaperone for EBV or Rh-LCV gH. The Rh-LCV gH homologue supported more fusion than EBV gH with an epithelial cell and supported the highest levels of fusion with a B cell. Chimeric constructs made from Rh-LCV gH and EBV gH that have 85.4 % sequence identity should prove useful for mapping the regions of gH that are of importance to fusion as a whole and to B-cell fusion in particular.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622614      PMCID: PMC2396492          DOI: 10.1099/vir.0.82949-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

2.  Product review. New mammalian expression vectors.

Authors:  B Moss; O Elroy-Stein; T Mizukami; W A Alexander; T R Fuerst
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

3.  Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42.

Authors:  R Jiang; R S Scott; L M Hutt-Fletcher
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion.

Authors:  Liguo Wu; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2007-02-20       Impact factor: 3.616

5.  Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect.

Authors:  X Wang; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  An Epstein-Barr-related herpesvirus from marmoset lymphomas.

Authors:  Y Cho; J Ramer; P Rivailler; C Quink; R L Garber; D R Beier; F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

7.  Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.

Authors:  Pierre Rivailler; Young-Gyu Cho; Fred Wang
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

9.  Chaperone functions common to nonhomologous Epstein-Barr virus gL and Varicella-Zoster virus gL proteins.

Authors:  Q Li; C Buranathai; C Grose; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

10.  Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells.

Authors:  Liguo Wu; Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more
  11 in total

1.  Mapping regions of Epstein-Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH/gL.

Authors:  Aileen E Plate; Jessica J Reimer; Theodore S Jardetzky; Richard Longnecker
Journal:  Virology       Date:  2011-03-03       Impact factor: 3.616

2.  The conserved disulfide bond within domain II of Epstein-Barr virus gH has divergent roles in membrane fusion with epithelial cells and B cells.

Authors:  Britta S Möhl; Karthik Sathiyamoorthy; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

3.  Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.

Authors:  Gabriela M Escalante; Lorraine Z Mutsvunguma; Murali Muniraju; Esther Rodriguez; Javier Gordon Ogembo
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

4.  Functional analysis of glycoprotein L (gL) from rhesus lymphocryptovirus in Epstein-Barr virus-mediated cell fusion indicates a direct role of gL in gB-induced membrane fusion.

Authors:  Aileen E Plate; Jasmina Smajlović; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

5.  Comparative pathobiology of macaque lymphocryptoviruses.

Authors:  Angela Carville; Keith G Mansfield
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

6.  Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.

Authors:  Marissa Herrman; Janine Mühe; Carol Quink; Fred Wang
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

7.  Characteristics of Epstein-Barr virus envelope protein gp42.

Authors:  Pamela L Shaw; Austin N Kirschner; Theodore S Jardetzky; Richard Longnecker
Journal:  Virus Genes       Date:  2010-02-17       Impact factor: 2.332

8.  Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus.

Authors:  Swati Singh; Leah J Homad; Nicholas R Akins; Claire M Stoffers; Stefan Lackhar; Harman Malhi; Yu-Hsin Wan; David J Rawlings; Andrew T McGuire
Journal:  Cell Rep Med       Date:  2020-06-23

9.  Epstein-Barr virus LF2: an antagonist to type I interferon.

Authors:  Liguo Wu; Even Fossum; Chul Hyun Joo; Kyung-Soo Inn; Young Chul Shin; Eric Johannsen; Lindsey M Hutt-Fletcher; Juergen Hass; Jae U Jung
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

10.  Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model.

Authors:  Janine Mühe; Pyone Pyone Aye; Carol Quink; Jing Ying Eng; Kathleen Engelman; Keith A Reimann; Fred Wang
Journal:  Cell Rep Med       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.